CONFIRM anti-Epidermal Growth Factor Receptor (3C6) Primary Antibody

This antibody is intended for in vitro diagnostic (IVD) use.

Ventana Medical Systems' (Ventana) CONFIRM anti-Epidermal Growth Factor Receptor (EGFR) (3C6) Primary Antibody is a mouse monoclonal antibody (IgG1) directed against the extracellular domain of human EGFR protein of 170kD. The antibody also recognizes the type III variant of 145kD. This antibody is intended for laboratory use, via light microscopy, for the qualitative detection of EGFR in formalin-fixed, paraffin-embedded tissue on a Ventana automated slide stainer.

The clinical interpretation of any staining, or the absence of staining, must be complemented by morphological studies and evaluation of proper controls. Evaluation must be made by a qualified pathologist within the context of the patient’s clinical history and other diagnostic tests. Prescription only.